These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 2900129

  • 1. Experimental studies on the neurocardiovascular effects of urapidil.
    Gillis RA, Kellar KJ, Quest JA, Namath IJ, Martino-Barrows A, Hill K, Gatti PJ, Dretchen K.
    Drugs; 1988; 35 Suppl 6():20-33. PubMed ID: 2900129
    [Abstract] [Full Text] [Related]

  • 2. Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.
    Kolassa N, Beller KD, Sanders KH.
    Am J Cardiol; 1989 Aug 15; 64(7):7D-10D. PubMed ID: 2569265
    [Abstract] [Full Text] [Related]

  • 3. Importance of central nervous system serotonin-1A receptors for mediating the hypotensive effect of urapidil.
    Mandal AK, Kellar KJ, Friedman E, Pineo SV, Hamosh P, Gillis RA.
    J Pharmacol Exp Ther; 1989 Nov 15; 251(2):563-70. PubMed ID: 2530339
    [Abstract] [Full Text] [Related]

  • 4. Involvement of 5-HT1A receptors in blood pressure reduction by 8-OH-DPAT and urapidil in cats.
    Sanders KH, Beller KD, Kolassa N.
    J Cardiovasc Pharmacol; 1990 Nov 15; 15 Suppl 7():S86-93. PubMed ID: 1702492
    [Abstract] [Full Text] [Related]

  • 5. Interaction of urapidil with brain serotonin-1A receptors increases the blood pressure reduction due to peripheral alpha-adrenoceptor inhibition.
    Sanders KH, Beller KD, Bischler P, Kolassa N.
    J Hypertens Suppl; 1988 Dec 15; 6(2):S65-8. PubMed ID: 2906703
    [Abstract] [Full Text] [Related]

  • 6. The role of serotonin-1A receptor activation and alpha-1 adrenoceptor blockade in the hypotensive effect of 5-methyl-urapidil.
    Mandal AK, Kellar KJ, Gillis RA.
    J Pharmacol Exp Ther; 1991 May 15; 257(2):861-9. PubMed ID: 1674536
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [3H]5-methyl-urapidil labels 5-HT1A receptors and alpha 1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies.
    Laporte AM, Schechter LE, Bolaños FJ, Vergé D, Hamon M, Gozlan H.
    Eur J Pharmacol; 1991 May 30; 198(1):59-67. PubMed ID: 1680714
    [Abstract] [Full Text] [Related]

  • 9. Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil.
    Doods HN, Boddeke HW, Kalkman HO, Hoyer D, Mathy MJ, van Zwieten PA.
    J Cardiovasc Pharmacol; 1988 Apr 30; 11(4):432-7. PubMed ID: 2453746
    [Abstract] [Full Text] [Related]

  • 10. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
    Gillis RA, Hill KJ, Kirby JS, Quest JA, Hamosh P, Norman WP, Kellar KJ.
    J Pharmacol Exp Ther; 1989 Feb 30; 248(2):851-7. PubMed ID: 2521902
    [Abstract] [Full Text] [Related]

  • 11. Influence of urapidil and 8-OH-DPAT on brain 5-HT turnover and blood pressure in rats.
    Valenta B, Kotai E, Weisz E, Singer EA.
    J Cardiovasc Pharmacol; 1990 Feb 30; 15 Suppl 7():S68-74. PubMed ID: 1702489
    [Abstract] [Full Text] [Related]

  • 12. Comparative effects of urapidil, prazosin, and clonidine on ligand binding to central nervous system receptors, arterial pressure, and heart rate in experimental animals.
    Kellar KJ, Quest JA, Spera AC, Buller A, Conforti A, Dias Souza J, Gillis RA.
    Am J Med; 1984 Oct 05; 77(4A):87-95. PubMed ID: 6091452
    [Abstract] [Full Text] [Related]

  • 13. Evidence that different regional sympathetic outflows vary in their sensitivity to the sympathoinhibitory actions of putative 5-HT1A and alpha 2-adrenoceptor agonists in anaesthetized cats.
    Ramage AG, Wilkinson SJ.
    Br J Pharmacol; 1989 Dec 05; 98(4):1157-64. PubMed ID: 2575414
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alpha 1-adrenoceptor blockade and/or 5-HT1A agonism during treadmill exercise in dogs.
    Grohs JG, Fischer G, Huber S, Raberger G.
    J Auton Pharmacol; 1991 Apr 05; 11(2):101-7. PubMed ID: 1675216
    [Abstract] [Full Text] [Related]

  • 16. On the mechanism of the hypotensive action of urapidil.
    Bousquet P, Feldman J, Schwartz J.
    J Hypertens Suppl; 1985 Dec 05; 3(3):S187-9. PubMed ID: 2856701
    [Abstract] [Full Text] [Related]

  • 17. [Cardiovascular effects of urapidil].
    Bousquet P, Decker N, Feldman J, Schwartz J.
    J Pharmacol; 1983 Dec 05; 14(4):465-72. PubMed ID: 6672466
    [Abstract] [Full Text] [Related]

  • 18. 5-HT1A-agonistic properties of naftopidil, a novel antihypertensive drug.
    Borbe HO, Metzenauer P, Szelenyi I.
    Eur J Pharmacol; 1991 Nov 19; 205(1):105-7. PubMed ID: 1839829
    [Abstract] [Full Text] [Related]

  • 19. Effects of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity, blood pressure and heart rate in anaesthetized rats and cats.
    Sanders KH, Jurna I.
    Eur J Pharmacol; 1985 Apr 02; 110(2):181-90. PubMed ID: 3987812
    [Abstract] [Full Text] [Related]

  • 20. 8-OH-DPAT, flesinoxan and guanfacine: systemic and regional haemodynamic effects of centrally acting antihypertensive agents in anaesthetized rabbits.
    Hof RP, Fozard JR.
    Br J Pharmacol; 1989 Apr 02; 96(4):864-71. PubMed ID: 2568144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.